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Distortion of mannoimidazole supports a B2,5
boat transition state for the family GH125
α-1,6-mannosidase from Clostridium perfringens
Alexandra Males, a Gaetano Speciale,b Spencer J. Williams *b and
Gideon J. Davies *a
Enzyme transition-state mimics can act as powerful inhibitors
and allow structural studies that report on the conformation of
the transition-state. Here, mannoimidazole, a mimic of the tran-
sition state of mannosidase catalyzed hydrolysis of mannosides, is
shown to bind in a B2,5 conformation on the Clostridium perfrin-
gens GH125 α-1,6-mannosidase, providing additional evidence of
a OS2–B2,5–
1S5 conformational itinerary for enzymes of this
family.
A conformational itinerary describes how a molecule changes
shape along a reaction coordinate. For reactions catalysed by
enzymes, the three-dimensional fold of the protein and its
electrostatic microenvironment provides constraints such
that well-defined conformational itineraries are observed.
These conformational itineraries may diﬀer from those
observed for chemically-catalyzed reactions in the gas or con-
densed phase, but nonetheless must still obey stereoelectro-
nic dictates of chemical reactivity. The study of conformation-
al itineraries of enzymes has been assisted by the full spec-
trum of kinetic, computational and structural methods.1,2 In
the case of glycoside hydrolases, conformational itineraries
are often assigned through determination of the three-dimen-
sional structures of ligands bound to enzymes, most com-
monly substrate (Michaelis), intermediate, and product com-
plexes, and by using inhibitors that mimic the transition
state.3
GHs have been grouped into >150 families on the basis of
primary sequence and ability to cleave specific glycoside
substrates.4,5 As sequence defines the three-dimensional
structure of proteins, family members typically adopt similar
folds and possess highly conserved amino acids within their
active site clefts. The chemical mechanisms through which
family members perform catalysis tend to be conserved
across a family and lead to substrate hydrolysis with either
retention or inversion of anomeric stereochemistry.6
Inversion of stereochemistry occurs in a single step reaction
when water acts as a nucleophile. Retention of stereo-
chemistry is typically achieved through a two-step substi-
tution mechanism involving participation by an enzymic
nucleophile or by a pendant neighboring group on the
substrate.6–8 Both pathways benefit from enzymatic amino
acids that provide general acid catalysis to promote the depar-
ture of the anomeric groups, and general base catalysis to
promote nucleophilic attack by water. In almost all cases the
transition states possess oxocarbenium-ion-like character and
the stability of this TS is greatest when partial double bond
character is maximized between C1 and O5, which occurs
when the system C5–O5–C1–C2 is planar.9 Such transition-
state conformations include two boats: B2,5 and
2,5B; two half-
chairs: 4H3 and
3H4 (Fig. 1a); and the related envelopes:
3E,
E3,
4E and E4. As transition state mimicry is a powerful strat-
egy for inhibitor design, eﬀorts have been made to assign
conformational itineraries, and in particular the TS confor-
mation, for a large number of GH families.1,2
Mannosidases and mannanases catalyze the hydrolysis of
mannoside linkages and these enzymes are found within 11
GH families. Enzymes within families GH2, 5, 26, 38, 76, 92,
99, 113, 125 and 134 perform catalysis through itineraries
along the OS2–B2,5–
1S5 region of conformational space whereas
enzymes of families GH47 and 134 react through the
3S1–
3H4–
1C4 conformational axis (Fig. 1b). The use of mannoi-
midazole and analogues thereof have been instrumental in the
assignment of conformational itineraries and transition state
conformation (Table 1).
In the case of family GH125, the conformational itinerary
remained elusive for many years. Initial X-ray structures
of the foundation member CpGH125 exo-α-1,6-mannosidase
(CpGH125) with the nonhydrolyzable substrate mimic methyl
1,6-α-thiomannobioside (1) (Protein Databank (PDB) ID: 3QT9)
and deoxymannojirimycin (2) (PDB ID: 3QRY) revealed undis-
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torted, ground-state 4C1 conformations (Fig. 2a).
18 Instead, a
computational approach involving ab initio QM/MM meta-
dynamics was used to model the conformation of substrate,
1,6-α-mannobiose, in the enzyme active site, by in silico substi-
tution of the sulfur in the experimentally determined X-ray
structure.19 This calculation predicted that the O-glycoside
favoured an OS2 conformation on-enzyme and hinted at an
OS2 → B2,5
‡
→
1S5 conformational itinerary, which was fully
supported by QM/MM simulations of the reaction mechanism
(Fig. 2b). Direct experimental support for this mechanism was
obtained through determination of the Michaelis complex for
the catalytically-disabled acid mutant (D220N) of CpGH125 in
complex with 1,6-α-mannobiose, which revealed an OS2 confor-
mation consistent with the computational predictions.19
As the ultimate determinant of the activation barrier for cat-
alysis, the TS is the cardinal feature of the conformational itin-
erary. Mannoimidazole (3) (MIm) has emerged as a powerful
chemical probe for TS conformation of mannosidases owing
to its flattened nature, with an sp2-hybridized anomeric centre
and energetically feasible access to all of the possible stereo-
electronically-compliant conformations expected for an oxocar-
benium ion-like transition state (Fig. 2b).3 Indeed, for a single
step reaction, determination of the conformation of the tran-
sition state allows prediction of the conformational itinerary
(from substrate to product via the TS) by invoking the principle
of least nuclear motion.21 This principle states that elementary
reactions that involve the least change in atomic position and
electronic configuration will be favoured. Given the impor-
tance of the TS conformation in a reaction coordinate, and the
utility of MIm in assigning conformational itineraries, we
chose to revisit family GH125 to gather additional evidence in
support of the proposed conformational itinerary. Here we
report an X-ray structure of mannoimidazole (3) bound to wild-
type CpGH125 that provides compelling evidence in support of
a ‘latitudinal’ OS2 → B2,5
‡
→
1S5 conformational itinerary, com-
plementing previous computational and structural data.
Results and discussion
Glycoimidazoles have been argued to act as glycosidase inhibi-
tors through ‘lateral’ protonation of the imidazole nitrogen
lone pair by the enzymatic general acid approaching in the
plane of the imidazole ring.22 In fact, this interaction served as
the basis for an early classification of glycosidases into syn and
anti protonators, based on whether their general acid residues
are situated syn or anti to the substrate C1–O5 bond (Fig. 2c).23
However, analysis of published complexes with GH125
enzymes shows that the general acid residue is located below
the mean plane of the ring,18,19 suggesting that there are poor
prospects for binding of MIm to CpGH125. Yet, there are now
several examples of glycoimidazoles binding to glycosidases
with good aﬃnity even without achieving a prototypical inter-
action between the enzymatic general acid and the imidazole
nitrogen, such as β-glucosidases of family GH116,24
α-mannanases of family GH9925 and α-mannosidases of family
GH4710 (Fig. 2d). The success of these cases inspired us to
investigate binding of MIm to CpGH125.
We studied the thermodynamics for binding of MIm to
CpGH125 using isothermal titration calorimetry (Fig. 3a).
Analysis of the calorimogram using a one site binding model
allowed prediction of binding at 3.2 sites with an overall KD
value of 1.6 mM. Using a sequential binding site model, indi-
vidual dissociation constants can be calculated at each site
yielding values of 40 μM, 105 μM, and 3.1 mM. However,
whilst this is indicative of multiple binding sites, it is not clear
that the individual KD values are accurately determined by the
Table 1 Proposed transition state conformation of mannosidases from
various glycoside hydrolase families. Families for which the transition
state conformation has been assigned on the basis of mannoimidazole
complexes are indicated with an asterisk (*)
Transition state conformation
3H4
‡ B2,5
‡
α-Mannosidases 47* (ref. 10) 38*,3 76,11 92*,12 125*a
β-Mannosidases 134 (ref. 13) 2*,14 5*,15 26*,3,16 113*,3 130 17
a This work.
Fig. 1 (a) Common half-chair and boat transition state conformations,
illustrated for α-glycosidases. (b) Common mannosidase conformational
itineraries shown on a Mercator plot with that for GH125 highlighted in
green. Shown in blue is the 3S1–
3H4–
1C4 itinerary used by GH47 and 134
enzymes. The transition states are represented by a green triangle and a
blue square.
Communication Organic & Biomolecular Chemistry
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data. In order to gain evidence that binding by MIm, as shown
by ITC, results in enzyme inhibition, we determined its IC50
value. At a concentration of 0.5 mM DNPMan, we determined
an IC50 of 1.7 mM (Fig. 3b), consistent with the overall ITC
figure of 1.6 mM; this IC50 value cannot be converted to a KI
value since the substrate does not give saturation kinetics and
so KM cannot be determined.
Binding stoichiometry of >1 for basic sugar-shaped hetero-
cycles is unusual and suggests that the ligand may not solely
be binding at the −1 subsite. Previous work has identified
three subsites, −1, +1 and +2, in CpGH125 through a complex
with 1,6-α-mannotriose (PDB ID: 5M7Y),19 and studies of a dis-
accharide substrate that binds in the −1/+1 subsites revealed
saturation kinetics, whereas a monosaccharide substrate, 2,4-
dinitrophenyl α-mannoside (DNPMan), that bound only in the
−1 subsite did not.18,26 Previous poor electron density in the
+2 subsite suggests that this may represent the low aﬃnity
binding site, a conclusion supported by subsequent X-ray crys-
tallographic studies (vide infra). The two tighter aﬃnities there-
fore should likely reflect binding at the −1 and +1 subsites;
however, we cannot draw conclusions as to which value is
assigned to each of these subsites. Nevertheless, the interest-
ing ITC data encouraged eﬀorts to determine the 3D structure
of a complex of CpGH125 with mannoimidazole.
Fig. 2 (a) Structures of methyl α-thiomannobioside, deoxymannojirimycin and mannoimidazole. (b) Mechanism showing distortion of mannose
from an OS2 conformation to
1S5, via a B2,5 transition state, a credible conformational itinerary of GH125 α-mannosidases. (c) syn and anti trajectory
of the protonator/general acid residue in respect to the carbohydrate ligand. (d) Conformational free energy landscape of mannoimidazole in
complex with a variety of GH family mannosidases. 1 + 2: β-Man-1,4-MIm bound to GH26 CjMan26C and GH113 AaManA;3 3: MIm bound to GH2
BtMan2A;14 4: MIm bound to GH47 CkMan47;10 5 + 6: MIm bound to GH38 DmGManII;3,20 7: MIm bound to GH92 BtMan3990;12 * (asterisk) rep-
resent MIm bound to CpGH125 (this work).
Organic & Biomolecular Chemistry Communication
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Preformed crystals of CpGH125 recombinantly expressed in
E. coli were soaked with MIm and the structure of the complex
was solved at 1.85 Å resolution (Table 2). The crystal form con-
tains 2 monomers in the asymmetric unit. Density for MIm
was observed both in the −1 and +1 subsites, but not in the +2
subsite (Fig. 4a). The MIm molecule in the −1 subsite bound
in a B2,5 conformation and the MIm molecule in the +1 subsite
bound in a 4H3 conformation. The occupancy of MIm in the
−1 subsite was estimated to be 80% and 70% for monomer A
and B, respectively; the occupancy of MIm in the +1 subsite
was 100% for both monomers. These observations are consist-
ent with tight binding of MIm at the −1/+1 subsites, and
weaker binding at the +2 subsite.
MIm molecules in each site engage with a range of active
site residues (Fig. 4a). Key interactions with the −1 subsite
MIm include the carbonyl oxygen of Ser219 with O2, Oδ1 of
Asn302 with O3, Oδ1 and Oδ2 of Asp65 with O4 and O6,
respectively, and NH2 of Arg405 with O6. The general base
Glu393 is 2.3 Å away from a water poised for inline attack at
the ‘anomeric carbon’ of MIm. Major interactions with MIm in
subsite +1 include Oδ1 of Asp195 with O2, Glu129 Oε1 with O3
and Oε2 with O4, and the terminal amine nitrogen, NZ of
Lys131 and NH2 of Arg188 with O3. The catalytic amino acid,
Fig. 3 (a) Raw thermodynamic data obtained by isothermal titration
calorimetry. Top: injection proﬁle with the baseline in red; bottom: titra-
tion curve with the ﬁtting curve in blue. (b) IC50 curve of MIm against
GH125 using the monosaccharide substrate DNPMan.
Table 2 Data collection and reﬁnement statistics of CpGH125 and MIm
Resolution [Å] 84.8–1.85 (1.89–1.85)a
Rmerge 0.08 (0.51)
CC(1/2) 0.99 (0.54)
Completeness [%] 99.7 (99.9)
Rwork/Rfree 0.20/0.24
RMSDbonds [Å] 0.01
PDB code 6RQK
a Values in parentheses are for highest-resolution shell.
Fig. 4 (a) Complex of CpGH125 with mannoimidazole in the −1 and +1
subsites. The residues of the enzyme that form hydrogen bonding inter-
actions and close contacts with mannoimidazole (<3 Å distance) are
shown in blue and the nucleophilic water molecule is depicted by a red
sphere. The electron density map is a REFMAC maximum-likelihood/σA-
weighted 2 Fo − Fc synthesis contoured at 0.75 electrons Å
−3 and 1.20
electrons Å−3 clipped to MIm in the −1 and +1 subsite, respectively. (b)
Superposition of CpGH125 in complex with MIm (monomer A) and 1,6-
α-mannobiose (PDB ID: 5M7I), shown in purple. Hydrogen bonds shown
in black between the catalytic residues of CpGH125 and nucleophilic
water.
Communication Organic & Biomolecular Chemistry
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Asp220, interacts with O6 of MIm in the +1 subsite. Trp116 is
stacked parallel to the imidazole of MIm, with CZ2 of Trp119
and N2 of MIm spaced 3.79 Å apart.
Overlay of the complex of MIm with wildtype CpGH125 with
that of the D220N mutant of the same enzyme with 1,6-
α-mannobiose (PDB ID: 5M7I) is shown in Fig. 4b. This shows
that the two MIm molecules bind such that their carbohydrate
rings are well-matched with the equivalent mannose rings of
1,6-α-mannobiose. Moreover, the general acid (Asp220; or
variant Asn220), and general base (Glu393) residues occupy
similar positions in space. This overlay highlights that the
interaction of Asp220 with the +1 subsite MIm molecule, in
the complex determined here, can be considered equivalent to
the interaction of Asn220 with the inter-glycosidic oxygen of
1,6-α-mannobiose seen in the CpGH125-D220N complex. Both
complexes include a well-defined water molecule hydrogen-
bonded to Glu393 and O3 of the −1 subsite MIm that is poised
to undertake a nucleophilic attack at the anomeric centre. The
interaction of this water molecule with O3 assists in orientat-
ing the water molecule to perform an in-line attack on C1
(Fig. 2b).
Nerinckx generalized the concept of syn/anti protonation to
consider divergence from canonical orientation in the mean
plane of the ring to include orientations in a syn or anti hemi-
sphere (Fig. 2c).27 According to this extended concept,
CpGH125 can be considered a syn protonator and with the
present work CpGH125 joins a growing list examples of glycosi-
dases that can bind glycoimidazoles even without achieving
lateral protonation. While binding is seen in this and related
cases, presumably the potency of binding is less than what
might be expected for an ideally located general acid that can
achieve such an interaction, an expectation that is borne-out
by much tighter binding to canonical anti-protonators such as
Bt3130 and Bt3965 from Bacteroides thetaiotaomicron GH92 (Ki
= 1.0 and 0.4 μM, respectively) whereas other α-mannosidases
from B. thetaiotaomicron have a Ki values ranging from
40–6000 μM.12 Also, imidazole-substituted mannoimidazoles
can exhibit even tighter binding, for example, the
β-mannosidase BtMan2A (from family GH2) binds phenethyl-
mannoimidazole with Ki = 57 nM compared to binding to
mannoimidazole with Ki = 1400 nM.
14 In this case since the
inhibitor lies across both the −1 and +1 subsite, the number
of interactions the inhibitor can make with the protein
increases. We highlight one important anomalous case, in
which a complex of a disaccharide MIm analogue with
BxGH99 1,2-α-mannanase revealed an unusual 2H3/E3 confor-
mation possibly due to steric clashes with an active site
residue, Tyr252.25 In this case no KD value could be measured
by ITC indicating poor aﬃnity for the enzyme.
Conclusions
The present work builds upon prior computational and struc-
tural studies of CpGH125 focussed on the Michaelis complex
that provided evidence for an OS2→ B2,5
‡
→
1S5 conformational
itinerary (Fig. 4). The present TS mimicking complex with
MIm in a B2,5 conformation provides compelling evidence for
this conformation in the transition state of this enzyme. Since
the free energy landscape3 for MIm reveals that the most
stable conformations for this inhibitor in the gas phase are
the 4H3 and
3H4 conformations, with the B2,5 conformation
some 6 kcal mol−1 less stable, the observation of a B2,5 confor-
mation provides persuasive evidence that this conformation is
induced upon binding because of the enzyme’s strong prefer-
ence for stabilizing a transition state with this conformation.
Combined with the previously published Michaelis complex in
an OS2 conformation, we now have crystallographic ‘snapshots’
of states that together define two of the three critical points
along the reaction coordinate of family GH125 enzymes.
Experimental
Expression, purification and crystallisation of CpGH125WT
Wild-type CpGH125 was expressed and purified under the
same conditions as the mutant, CpGH125-D220N.19 CpGH125,
at 12 mg ml−1, was crystallised under 0.2 M MgCl2, 0.1 M
HEPES pH 7.0 and 24% PEG 3350, protein : reservoir ratio
0.3 : 0.5 µL conditions and subsequently soaked with mannoi-
midazole. Crystals were soaked in 5 mM inhibitor for 2 h at
20 °C and then cryoprotected stepwise in 25% ethylene glycol
before snap freezing in liquid nitrogen.
Data were collected on Diamond MX beamline I24 and pro-
cessed using xia2 3dii.28 Integrated data were processed using
the CCP4 software suite;29 the programs used were
aimless,30,31 MOLREP32 with 5M7I as the reference model and
cycles of REFMAC533–38 and COOT39 for refinement of the
structure. CpGH125 structures figures were produced using
CCP4 mg.40 Coordinate and observed structure-factor ampli-
tudes have been deposited on the PDB with accession code
6RQK.
Measurement of dissociation constant (KD) by isothermal
titration calorimetry
CpGH125 and MIm were buﬀer matched by dialysis into
20 mM HEPES pH 7.0 and 200 mM NaCl. MIm was added by
syringe to a solution of CpGH125 in the calorimeter cell using
a MicroCal ITC200 calorimeter at 25 °C with 20 injections. The
concentration of CpGH125 was 200 µM and the ligand concen-
tration was varied between 4 mM and 36 mM to obtain a con-
sistent KD value. The binding aﬃnity was obtained using one
site fitting and a sequential binding fit (3 sites) within the
Origin7 software. The association constant (KA) was converted
to a dissociation constant using the equation KD = 1/KA. An
average over 5 experiments was taken to obtain accurate KD
values for the three subsites.
Measurement of inhibition constant (IC50) of MIm
Enzyme assays were performed in 40 μL quartz cuvettes with
path lengths of 10 mm. Change in absorbance values at
405 nm were monitored using a Cary UV-Vis spectrophoto-
Organic & Biomolecular Chemistry Communication
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meter. Reactions were initiated by addition of CpGH125 at
9.05 μM to a solution of 0.5 mM DNPMan in PBS buﬀer (pH
7.4) at 37 °C. Rates were measured by observing change in
absorption for 3 min. Each reaction was performed in tripli-
cate and averaged, and the data fit to a Hill plot.
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